Clinical Trials Logo

Japanese clinical trials

View clinical trials related to Japanese.

Filter by:
  • None
  • Page 1

NCT ID: NCT04238650 Completed - Healthy Volunteers Clinical Trials

A Pharmacokinetic Study Comparing MB02 And EU Avastin® In Healthy Male Volunteers

Start date: August 2, 2019
Phase: Phase 1
Study type: Interventional

A Randomised, Double Blind, Two-Arm, Single Dose, Parallel Phase I Study To Compare the Pharmacokinetics, Safety and Immunogenicity of MB02 (a Proposed Bevacizumab Biosimilar Drug) and EU Approved Avastin® in Japanese Healthy Male Volunteers. During the course of the study, the similarity in pharmacokinetics will be assessed by sampling the levels of drug in the blood, and by comparing these levels among the different administration arms. Safety, tolerability, and immunologic response to the administered drugs will also be evaluated throughout.

NCT ID: NCT03250598 Completed - Healthy Clinical Trials

Study to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian Origin

Start date: August 9, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this Phase I, single-dose, open-label trial is to evaluate the pharmacokinetics, safety, and effect on QTc interval of AG-348 in healthy, adult Japanese and Non-Asian subjects. The study plans to evaluate 3 cohorts of a single oral dose of AG-348 in Japanese and Non-Asian subjects. Pharmacokinetic sampling will take place serially at specified times during conduct of the study.

NCT ID: NCT02533375 Completed - Adalimumab Clinical Trials

Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

Start date: September 28, 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study was to investigate the efficacy, safety, and pharmacokinetics of adalimumab in Japanese participants with generalized pustular psoriasis (GPP) who did not have an adequate response to their currently approved treatment.

NCT ID: NCT01655056 Completed - Healthy Subjects Clinical Trials

A Study to Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the Body

Start date: June 2006
Phase: Phase 1
Study type: Interventional

The study aims to investigate the effect of YM150 and to compare gender and ethnic differences in healthy Caucasian and Japanese male and female subjects.